Evaluation of the incidence and outcome of gestational diabetes mellitus using the current international consensus guidelines for diagnosing hyperglycaemia in pregnancy


  • Ganga Sagar Tiwary Department of Obstetrics and Gynecology, Armed Medical College, Pune, Maharashtra, India
  • Meenakshi K. Bharadwaj Department of Obstetrics and Gynecology, Armed Medical College, Pune, Maharashtra, India
  • Manash Biswas Department of Obstetrics and Gynecology, Armed Medical College, Pune, Maharashtra, India
  • Madhusudan Dey Department of Obstetrics and Gynecology, Armed Medical College, Pune, Maharashtra, India




GDM, OGTT, NGT, IADPSG, HAPO, Incidence, Glycemic control, Maternal and neonatal outcome


Background: GDM is defined as carbohydrate intolerance of variable severity with onset or first recognition during pregnancy. It may be appropriate to screen pregnant women belonging to high-risk populations during the first trimester of pregnancy in order to detect previously undiagnosed Diabetes Mellitus. Formal systematic testing for Gestational Diabetes is usually done between 24 to 28 weeks of gestation. Even though there are many diagnostic criteria and guidelines for management of GDM, there still exists lack of consensus regarding diagnosis and management of patients with GDM. After HAPO study, IADPSG has formulated a new consensus guideline for diagnosing hyperglycaemia in pregnancy which has formed the back bone for this particular study.

Methods: This prospective observational study was carried out for a period of one year from July 2014 to Jun 2015 at AFMC, Pune in Dept. of Obstetrics & Gynaecology. To determine if gestational diabetes is present in pregnant women, a standard OGTT was performed with 75 g glucose. The incidence of GDM in antenatal population visiting AFMC, Pune was calculated. Maternal and neonatal outcome was observed and was compared with those of euglycaemic antenatal population.

Results: The incidence of GDM in the antenatal population visiting AFMC, Pune was found to be 12.4%. Family history of Diabetes among first degree relatives is the commonest risk factor associated with GDM. It was found that, with adequate glycaemic control, most of the maternal as well as neonatal complications associated with GDM can be reduced to a level comparable with euglycaemic antenatal population.

Conclusions: The new international consensus guideline in diagnosing GDM has shown an incidence of GDM comparable with other criteria for diagnosing GDM. Ensuring an adequate glycaemic control throughout the antenatal period alleviates most of the maternal and neonatal complications associated with GDM.


American Diabetes Association Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care. 2009;32(1):S62-7.

Metzger BE, Coustan DR. Summary and Recommendations of the Fourth International workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 1998;21(2):B161-7.

International Association of diabetes and Pregnancy Study Groups (IADPSG) recommendations on the diagnosis and classification of Hyperglycemia in pregnancy. IADPSG consensus panel. Diabetes care. 2010;33:676-82.

Metzger BE, Gabbe SG, Perrson B. IADPSG recommendations on diagnosis and classification of hyperglycemia in pregnancy. IADPSG Study group panel. Diabetes Care. 2010;33:676-82.

HAPO Study Cooperative Research Group The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Intl J Gynaecol Obstet. 2002;78:69-77.

American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2015;38(1):S1-S93.

Divakar H, Tyagi S, Hosmani P. Diagnostic criteria influence prevalence rates for gestational diabetes: implications for interventions in an Indian pregnant population. Perinatology. 2008:10(6);155-61.

American college of Obstetrics and Gynecology. Gestational Diabetes. Pratice Bulletin no. 30. Obstet Gynecol. 2001;98:525-38.

Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(2):524-9.

Jovanovic L, Ilic S, Pettitt DJ, Hugo K, Gutierrez M, Bowsher RR, et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes care. 1999;22:1422-7.

Kjos SL, Leung A, Henry OA, Victor MR, Paul RH. Antepartum surveillance in diabetic pregnancies: Predictors of fetal distress in labor. Am J Obstet Gynecol. 1995;173:1532-9.

Detch JC, Almeida AC, Bortolini LG. Markers for diagnosis and treatment in 924 pregnancies with GDM. J Arq Bras Endocrinol Metabol. 2011;55(6):389-98.

Kwik M, Secho SK, Smith C. Outcome of pregnancies affected by Impaired Glucose Tolerance. J Diabetes Res Clin Pract. 2007:77(2):263-8.






Original Research Articles